Empty Intravenous (IV) Bags Global Market Report 2024

The empty intravenous (IV) bags market size has grown rapidly in recent years. It will grow from $5.63 billion in 2023 to $6.36 billion in 2024 at a compound annual growth rate (CAGR) of 13%. The expansion observed in the historical period can be attributed to several factors. These include the increased prevalence of chronic diseases, the high demand for intravenous therapies, the growth in the aging population, improvements in healthcare infrastructure, and the expansion of hospital and clinical services.

The empty intravenous (IV) bags market size is expected to see rapid growth in the next few years. It will grow to $10.41 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forecast period can be attributed to several factors. These include the expanding home healthcare market, the increasing incidence of malnutrition, rising demand for personalized medicine, the expansion of healthcare services in emerging markets, and the growing number of surgical procedures. Major trends expected in the forecast period encompass the development of smart IV bags equipped with sensors, the introduction of biodegradable IV bags, enhancements in sterility and contamination prevention measures, advancements in manufacturing techniques, and integration with electronic health records (EHR).

The growing number of surgical procedures is expected to drive the expansion of the empty intravenous (IV) bag market in the future. Surgical procedures involve invasive medical interventions to address various health conditions or injuries within the body. Factors contributing to the increase in surgical procedures include advancements in medical technology, an aging population, the prevalence of chronic diseases, improved healthcare access, and patient demand for treatment. Empty IV bags are essential for delivering vital fluids, medications, blood products, and anesthesia support during surgical procedures. For example, a report by the International Society of Aesthetic Plastic Surgery (ISAPS) noted a significant increase in both surgical and non-surgical procedures in 2021 compared to 2020, indicating the rising demand for medical interventions and subsequently, empty IV bags.

The high prevalence of chronic diseases is anticipated to fuel the growth of the empty IV bags market. Chronic diseases, which persist over an extended period and often require lifelong management, are on the rise due to factors such as aging populations, lifestyle changes, urbanization, obesity, healthcare access, stress, and mental health issues. Empty IV bags are crucial for preparing and administering personalized medication solutions, supporting home infusion therapy, providing nutrition and hydration, and facilitating palliative care. According to projections from the National Library of Medicine, the number of individuals affected by at least one chronic disease is expected to nearly double by 2050. This underscores the significant role of empty IV bags in managing chronic diseases and driving market growth.

Major companies in the empty IV bag market are prioritizing the development of innovative intravenous bag platforms to enhance patient safety. These platforms are advanced systems designed to ensure the safe and efficient delivery of intravenous medications and fluids. For instance, Fagron Sterile Services launched an Intravenous (IV) Bag Platform in March 2021 to meet the increased demand for sterile medications during and beyond the COVID-19 pandemic. The platform offers various medication presentations to hospitals and ambulatory surgery centers, featuring latex-free IV bags individually overwrapped for product protection and extended beyond-use dating.

Major companies operating in the empty intravenous (IV) bags market are Pfizer Inc., Fresenius Medical Care AG KGaA, Becton Dickinson and Company, Amcor LLC, Baxter International Inc., Grifols S.A., Hospira Inc., Nipro Corporation, B. Braun Medical Inc., ICU Medical Inc., RENOLIT Healthcare, Kiefel GmbH, Medisca Inc., Bioteque Corporation, BAUSCH Advanced Technology Group, Jorgensen Laboratories LLC, Technoflex, Sippex IV bags, AdvaCare Pharma Limited, Tacy Medical Inc., Polycine GmbH, JW Life Science Corp, Mitra Industries Private Limited.

North America was the largest region in the empty intravenous (IV) bags market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the empty intravenous (IV) bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the empty intravenous (IV) bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Empty intravenous (IV) bags serve as sterile, flexible containers intended for the direct administration of fluids, medications, or nutrients into a patient's bloodstream. These bags are essential in medical settings for the preparation and delivery of IV solutions, available in various sizes and materials, often equipped with ports for easy connection to IV lines and infusion sets.

The primary types of empty intravenous (IV) bags include single-chamber and dual-chamber varieties. A single-chamber empty IV bag is a sterile container used for preparing and administering fluids or medications intravenously, typically featuring a single compartment. These products are available in polyvinyl chloride and non-polyvinyl chloride variants, constructed from materials such as polypropylene, polyester ether, ethylene vinyl acetate, among others, offering capacities ranging from 50 ml to 100 ml, 100 ml to 250 ml, 250 ml to 500 ml, and above 500 ml. These bags find applications primarily in hospitals, clinics, and other medical settings.

The empty intravenous (IV) bag research report is one of a series of new reports that provides empty intravenous (IV) bag market statistics, including the empty intravenous (IV) bag industry's global market size, regional shares, competitors with an empty intravenous (IV) bag market share, detailed empty intravenous (IV) bag market segments, market trends and opportunities, and any further data you may need to thrive in the empty intravenous (IV) bag industry. This empty intravenous (IV) bag market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The empty intravenous (IV) bags market consists of sales of sterile IV bags, pressure-resistant bags, and light-protective bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.